Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of modafinil for idiopathic hypersomnia without long sleep time
2008-007033-41Phase 2Active
- Sponsor
- Hephata-Klinik
- Start
- Jan 2009
- Modality
- Vaccines & Immunotherapeutics, Cell Therapies, Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Phase 2, single-arm trial of gemogenovatucel-T in hypersomnolence disorder, sponsored by Hephata-Klinik. Primary endpoint: Change in Epworth Sleepiness Scale score. Started Jan 2009; status: active.
02
Drugs
gemogenovatucel-T
03
Conditions
hypersomnolence disorder
Beyond the preview
Go deeper on 2008-007033-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-007033-41.